Can a simple booklet help cancer patients ask the right questions?
NCT ID NCT02854293
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether giving cancer patients and their families a booklet of questions before a palliative care consultation helps them ask more questions or express more concerns. 121 adults with metastatic cancer and limited life expectancy took part. The booklet covered eight topics and was designed to make it easier for patients to ask about their prognosis without pressure.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Booklet-Question List
- What this could lead to
- If it works, this could give doctors a simple tool to help patients and families get the information they need during palliative care.
- What could go wrong
- This is a small, completed study that only measures how many questions are asked, not whether it improves quality of life or survival. Results may not apply to all settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
121 people
The number who actually took part.
- Start date
-
May 2012
- Finished
-
May 2015
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patient followed for metastatic cancer with or without specific treatment, with a limited life expectancy
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: * Patient over the age of 18 years, * Patient who has signed the informed consent form after being given a written information sheet * Patient followed for metastatic cancer with or without specific treatment, with a limited life expectancy * Patient referred to the palliative care team. * French-speaking Patient Exclusion criteria: * Cognitive disorders * Documented psychiatric disorders or marked psychological fragility
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Metastatic cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Alexis Vautrin
Nancy, 54519, France
-
Hopital René Huguenin
Saint-Cloud, 92210, France
-
Institut Curie
Paris, 75005, France
-
Léon Berard
Lyon, 69008, France
-
Polyclinique de l'Ormeau
Tarbes, 65000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug targets Sugar-Coated proteins on cancer cells
- Zapping a few growing tumors may keep breast cancer drugs working longer
- Can listening to music calm anxiety at the end of life?
- Can a platform trial match the right drug combo to each tumor?
- Can a new antibody help the immune system fight Hard-to-Treat tumors?
- Can a simple mouth rinse ease soreness for patients fed by tube?